John C.K. Milligan IV's Net Worth
$25.4 Million
Who is John C.K. Milligan IV?
John C.K. Milligan IV has an estimated net worth of $25.4 Million. This is based on reported shares in TherapeuticsMD, Inc..
SEC CIK
John C.K. Milligan IV's CIK is 0001532230
Past Insider Trading and Trends
2018 was John C.K. Milligan IV's most active year for acquiring shares with 18 total transactions. John C.K. Milligan IV's most active month to acquire stocks was the month of September. 2018 was John C.K. Milligan IV's most active year for disposing of shares, totalling 33 transactions. John C.K. Milligan IV's most active month to dispose stocks was the month of August. 2019 saw John C.K. Milligan IV paying a total of $472,700.00 for 569,000 shares, this is the most they've acquired in one year. In 2014 John C.K. Milligan IV cashed out on 723,412 shares for a total of $2,678,444.92, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TherapeuticsMD, Inc. (TXMD) Snapshot price: $2.24
Secretary/CEO subsidiaryJohn C.K. Milligan IV owns 5,644,890 units of Common Stock which is worth $12,644,553.60. From 2011 to 2021 John C.K. Milligan IV acquired a total of 2,938,569 shares in TherapeuticsMD, Inc. at a cost of $725,367.16, John also disposed a total of 3,679,511 shares of TherapeuticsMD, Inc. equalling to $13,517,222.69.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.50% | 59.25K |
$1.04 | -$46,022.08 | 1.75M |
May 10 - May 11
| |||
Form 4
| -14.44% | -285.78K |
$0.85 | $0.16 | 1.69M |
Jun 5 - Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 4
| +4.89% | 72K |
$2.75 | $198,000.00 | 1.54M |
Oct 25
| |||
Form 4
| +4.89% | 72K |
$2.75 | $198,000.00 | 1.54M |
Oct 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 28
| |||
Form 4
| +0.28% | 10K |
$2.93 | $29,300.00 | 3.58M |
Aug 16
| |||
Form 4
| +0.42% | 15K |
$3.16 | $47,400.00 | 3.57M |
Aug 12
| |||
Form 4
|
—
|
0
|
$1.90 | -$927,107.57 | 1.47M |
Scheduled
|
Dec 17 - Dec 18
| ||
Form 4
|
—
|
0
|
$2.43 | -$1,205,427.60 | 1.47M |
Scheduled
|
Dec 4 - Dec 6
| ||
Form 4
|
—
|
0
|
$2.53 | -$1,254,046.92 | 1.47M |
Scheduled
|
Nov 28 - Nov 29
| ||
Form 4
|
—
|
0
|
$2.50 | -$1,238,967.60 | 1.47M |
Scheduled
|
Nov 14 - Nov 15
| ||
Form 4
|
—
|
0
|
$2.72 | -$1,312,050.00 | 1.47M |
Scheduled
|
Oct 23 - Oct 24
| ||
Form 4
|
—
|
0
|
$2.97 | -$1,437,300.00 | 1.47M |
Scheduled
|
Oct 9 - Oct 10
| ||
Form 4
|
—
|
0
|
$3.44 | -$1,668,800.00 | 1.47M |
Scheduled
|
Sep 25 - Sep 26
| ||
Form 4
|
—
|
0
|
$3.10 | -$1,498,425.00 | 1.91M |
Scheduled
|
Aug 23 - Sep 11
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
| +1.16% | 20K |
$0.10 | $2,036.00 | 1.74M |
May 12
| |||
Form 4
| -8.32% | -353.41K |
$6.70 | -$2,366,835.51 | 3.89M |
Mar 26
| |||
Form 4
| -14.83% | -300.00K |
—
|
—
| 1.72M |
Mar 7
| |||
Form 4
| -0.39% | -25.00K |
$6.31 | -$157,691.34 | 6.32M |
Scheduled
|
Feb 24 - Feb 26
| ||
Form 4
| -0.39% | -25.00K |
$6.16 | -$153,918.07 | 6.34M |
Scheduled
|
Jan 28 - Jan 30
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16 - Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||